Retrospective Analysis of 12 Months Glaucoma Implant Efficacy: XEN45 and PreserFlo Microshunt

CONCLUSION: Both methods demonstrate satisfactory IOP control within a 12-month postoperative period with practically no serious adverse events/complications, but with relatively high numbers of subsequent interventions (needlings), particularly in the XEN45 group.PMID:35472784 | DOI:10.1055/a-1766-6444

Source: Klinische Monatsblatter fur Augenheilkunde - April 26, 2022 Category: Opthalmology Authors: Giulia Saletta Antonios Alexoudis Zisis Gkatzioufas Matthias Grieshaber Anthia Papazoglou Markus Tschopp Marc T öteberg Konstantin Gugleta Source Type: research